Resources from the same session
Optimising first-line treatment strategies in driver-positive lung cancer
Presenter: Pilar Garrido Lopez
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
Common themes in targeted therapy resistance across oncogene-driven NSCLC
Presenter: Sun Min Lim
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
New targets, new drugs: Promising therapies for KRAS (including non-G12C mutations), HER2, NRG1 and other new targets
Presenter: Joop De Langen
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
Q&A and discussion
Session: Best therapies with driver mutations in lung cancer
Resources:
Webcast